Pulse Biosciences Quarterly Balance Sheet
NASDAQ: PLSEHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Pulse Biosciences financial position
As of Jun 30, 2026, Pulse Biosciences reported total assets of $115.6 million, down 3.9% from a year earlier against total liabilities of $16.1 million. Shareholders' equity stood at $99.5 million, or 86.1% of assets. The company held $101.6 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 9.63, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Pulse Biosciences balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 101.62M | 68.32M | 80.73M | 95.21M | 106.35M | 119.28M | 118.04M | 79.03M | 26.20M | 34.88M | 44.37M | 50.39M |
| Receivables | 122.00K | 157.00K | 274.00K | 15.00K | — | — | 0 | — | — | — | — | — |
| Inventory | 236.00K | 206.00K | 136.00K | 57.00K | 51.00K | 30.00K | 0 | — | — | — | — | — |
| Total Current Assets | 105.70M | 71.13M | 83.42M | 97.16M | 108.16M | 120.91M | 119.45M | 80.41M | 27.24M | 35.85M | 45.33M | 51.62M |
| Property, Plant & Equipment | 1.06M | 1.02M | 1.05M | 1.05M | 1.11M | 1.06M | 1.16M | 1.22M | 1.31M | 1.40M | 1.53M | 1.65M |
| Goodwill | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M |
| Intangible Assets | 222.00K | 408.00K | 575.00K | 741.00K | 907.00K | 1.05M | 1.22M | 1.39M | 1.55M | 1.72M | 1.89M | 2.05M |
| Total Assets | 115.56M | 81.62M | 94.54M | 108.77M | 120.25M | 133.38M | 132.46M | 93.05M | 40.43M | 49.16M | 59.15M | 65.94M |
| Accounts Payable | 2.83M | 2.76M | 2.78M | 2.98M | 2.74M | 2.37M | 1.67M | 1.73M | 1.64M | 1.71M | 1.84M | 1.41M |
| Total Current Liabilities | 10.98M | 9.80M | 7.92M | 9.70M | 8.98M | 7.76M | 10.05M | 6.74M | 5.96M | 5.08M | 6.71M | 5.43M |
| Long-Term Debt | — | — | — | — | — | — | — | — | — | — | 0 | 0 |
| Total Liabilities | 16.06M | 15.32M | 13.88M | 16.07M | 15.76M | 14.93M | 17.60M | 13.91M | 13.46M | 12.88M | 14.79M | 13.80M |
| Shareholders' Equity | 99.50M | 66.30M | 80.66M | 92.69M | 104.49M | 118.45M | 114.86M | 79.13M | 26.97M | 36.29M | 44.36M | 52.15M |
| Retained Earnings | -506.52M | -481.86M | -463.28M | -445.85M | -426.46M | -407.30M | -390.50M | -371.12M | -358.44M | -347.05M | -336.92M | -324.98M |
| Total Debt | — | — | — | — | — | — | — | — | — | — | 0 | 0 |
| Net Cash (Debt) | 101.62M | 68.32M | 80.73M | 95.21M | 106.35M | 119.28M | 118.04M | 79.03M | 26.20M | 34.88M | 44.37M | 50.39M |
| Shares Outstanding | 70.80M | 68.23M | 67.84M | 67.74M | 67.28M | 67.27M | 65.93M | 61.52M | 55.23M | 55.23M | 55.14M | 54.99M |
This table shows 12 quarterly periods of Pulse Biosciences's balance sheet, from Q2 2026 back to Q3 2023, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow PLSE's reporting calendar. What is a balance sheet?